$232.52 Million in Sales Expected for Stevanato Group Spa (NYSE:STVN) This Quarter

Analysts be expecting that Stevanato Team Spa (NYSE:STVN – Get Ranking) will put up $232.52 million in profits for the current fiscal quarter, Zacks experiences. Four analysts have furnished estimates for Stevanato Group’s earnings, with the best gross sales estimate coming in at $238.31 million and the least expensive estimate coming in at $227.45 million. The company is scheduled to difficulty its up coming earnings benefits on Tuesday, June 14th.

In accordance to Zacks, analysts assume that Stevanato Team will report total 12 months profits of $1.03 billion for the existing yr, with estimates ranging from $1.02 billion to $1.04 billion. For the following 12 months, analysts anticipate that the business will report gross sales of $1.11 billion, with estimates ranging from $1.07 billion to $1.13 billion. Zacks Expenditure Research’s product sales averages are an ordinary centered on a study of promote-side analysts that that provide protection for Stevanato Team.

Stevanato Group (NYSE:STVN – Get Rating) past posted its earnings final results on Tuesday, March 8th. The enterprise reported €0.13 ($.14) EPS for the quarter, topping the Zacks’ consensus estimate of €0.10 ($.11) by €0.03 ($.03). The company had profits of €232.60 million all through the quarter, as opposed to analyst estimates of €220.57 million. Stevanato Team experienced a return on fairness of 21.52% and a web margin of 15.93%. The company’s profits was up 12.5% on a 12 months-around-yr basis.

Numerous analysts recently commented on the corporation. Bank of The us cut their price tag aim on Stevanato Group from $30.00 to $24.00 and set a “buy” rating for the firm in a report on Wednesday, March 9th. Citigroup decreased their focus on cost on Stevanato Group from $27.00 to $23.00 and set a “buy” ranking on the stock in a study report on Wednesday, March 9th. Morgan Stanley decreased their focus on rate on Stevanato Group from $30.00 to $22.00 and set an “overweight” rating on the inventory in a research report on Wednesday, March 9th. Wells Fargo & Corporation reduced their concentrate on price tag on Stevanato Group from $26.00 to $21.00 and established an “overweight” score on the stock in a analysis report on Wednesday, March 9th. Ultimately, Zacks Investment Research downgraded Stevanato Group from a “buy” score to a “hold” rating in a exploration report on Thursday, March 10th. Two investment analysts have rated the stock with a maintain rating and seven have issued a buy ranking to the stock. According to info from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an typical target rate of €24.69 ($27.13).

Shares of STVN traded down €0.40 ($.44) throughout buying and selling several hours on Friday, hitting €17.36 ($19.08). The inventory experienced a buying and selling volume of 232,090 shares, compared to its regular quantity of 300,761. The firm has a credit card debt-to-equity ratio of .24, a swift ratio of 2.12 and a current ratio of 2.56. Stevanato Group has a 12 month minimal of €14.38 ($15.80) and a 12 thirty day period substantial of €29.18 ($32.07). The stock has a fifty working day transferring typical price of €16.98 and a 200 working day going common cost of €21.60.

Many institutional investors have a short while ago created changes to their positions in STVN. Roubaix Money LLC acquired a new posture in shares of Stevanato Group in the 3rd quarter valued at about $3,078,000. WCM Financial investment Management LLC obtained a new posture in shares of Stevanato Team in the third quarter valued at about $55,213,000. Raymond James & Associates acquired a new place in shares of Stevanato Group in the third quarter valued at about $1,981,000. Dupont Cash Administration Corp acquired a new stake in shares of Stevanato Team in the third quarter really worth about $623,000. Last but not least, Kornitzer Capital Administration Inc. KS purchased a new stake in shares of Stevanato Group in the third quarter truly worth about $25,468,000. Institutional buyers and hedge money own 12.40% of the company’s stock.

Stevanato Group Firm Profile (Get Rating)

Stevanato Group S.p.A. is a supplier of drug containment, drug shipping and diagnostic remedies to the pharmaceutical, biotechnology and lifetime sciences industries. Stevanato Team S.p.A. is centered in PIOMBINO DESE, Italy.

Proposed Tales

Get a absolutely free copy of the Zacks study report on Stevanato Team (STVN)

For more details about investigation choices from Zacks Expense Exploration, stop by Zacks.com

Want Far more Great Investing Tips?

Get Information & Rankings for Stevanato Team Day by day – Enter your e-mail tackle down below to get a concise everyday summary of the hottest information and analysts’ scores for Stevanato Group and relevant corporations with MarketBeat.com’s Absolutely free each day email e-newsletter.